2024-07-02T16:06:47-05:00 2023-12-31 910189318 MOSS ADAMS LLP 4747 EXECUTIVE DR SUITE 1300 SAN DIEGO CA 92121 990 2023-01-01 873910792 SANFORD LABORATORIES FOR INNOVATIVE MEDICINES SANF 8583265227 3535 GENERAL ATOMICS COURT STE 200 SAN DIEGO CA 92121 MICHAEL DOLLAR CHIEF FINANCIAL OFFICER 8583265227 2024-07-02 1 MICHAEL DOLLAR 999009999 0 PATRICIA J MAYER P00188643 8586271400 2024-07-02 2 AAL1 IAL1 2023 2023-04-26 12:10:37Z KRISTIINA VUORI 3535 GENERAL ATOMICS COURT STE 200 SAN DIEGO CA 92121 12532763 0 X WWW.SANFORDLABS.ORG X 2021 CA SANFORD LABS IS A NOT-FOR-PROFIT PUBLIC BENEFIT BIOMEDICAL RESEARCH ORGANIZATION WITH A MISSION TO DISCOVER AND DELIVER NEXT-GENERATION PRECISION MEDICINES TO IMPROVE THE LIVES OF PATIENTS IN NEED. SANFORD LABS' GOAL IS TO EXPEDITE THE TRANSLATION OF SCIENTIFIC DISCOVERIES TO NOVEL MEDICINES BY LEVERAGING AN OPERATIONAL MODEL THAT IS DISTINCT FROM OTHER ACADEMIC AND NOT-FOR-PROFIT ORGANIZATIONS. 3 2 22 4 0 0 2000000 12000000 0 0 1082 532763 0 0 2001082 12532763 0 0 0 0 0 1483677 0 0 0 15825 2449540 15825 3933217 1985257 8599546 12004057 26076643 10018800 15491840 1985257 10584803 X SANFORD LABORATORIES FOR INNOVATIVE MEDICINES (SANFORD LABS) IS A NOT-FOR-PROFIT BIOMEDICAL RESEARCH ORGANIZATION WITH A MISSION TO DISCOVER AND DELIVER NEXT-GENERATION PRECISION MEDICINES TO IMPROVE THE LIVES OF PATIENTS IN NEED. 0 0 2578727 SANFORD LABORATORIES FOR INNOVATIVE MEDICINES (SANFORD LABS) IS AN INDEPENDENT, NOT-FOR-PROFIT COLLABORATIVE HUB WITH A MISSION TO ACCELERATE THE DEVELOPMENT OF NOVEL MOLECULAR MEDICINES FROM SCIENTIFIC DISCOVERY TO THE CLINIC. OUR CURRENT RESEARCH IS FOCUSED ON RNA THERAPEUTICS, A RAPIDLY EXPANDING CLASS OF DRUGS WITH THE POTENTIAL TO PROGRESS QUICKLY FROM CONCEPT TO PATIENT AND CHANGE THE STANDARD OF CARE FOR MANY LIFE-THREATENING DISEASES. (CONTINUED ON SCHEDULE O).OUR UNIQUE OPERATING MODEL FILLS A CRITICAL GAP FOR TRANSLATIONAL RESEARCH THAT DOES NOT FIT TRADITIONAL ACADEMIC LABS AND YET IS TOO EARLY FOR VENTURE OR INDUSTRY INVESTMENT. OUR RESEARCH TEAMS, LED BY TEAMS OF ENTREPRENEURIAL SCIENTISTS, ARE ORGANIZED AROUND THERAPEUTIC APPROACHES AND PLATFORM TECHNOLOGIES WITH BROAD APPLICABILITY TO A RANGE OF DISEASES, THUS ENABLING THE EFFICIENT PROTOTYPING OF MULTIPLE NEW MEDICINES IN PARALLEL. IN ADDITION TO OUR INTERNAL RESEARCH, WE ARE ACTIVELY FORGING COLLABORATIONS ACROSS THE DYNAMIC LIFE SCIENCE ECOSYSTEM AND AIM TO ENHANCE SAN DIEGO'S LEADERSHIP AS A WORLD-CLASS CLUSTER IN RNA BIOLOGY AND MEDICINES. 2578727 1 1 0 0 0 0 0 0 0 0 1 0 0 1 1 1 1 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 18 0 22 0 0 0 0 0 0 0 0 0 0 0 0 0 X 3 2 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 1 0 CA X LIGIA AMEZCUA 8583265227 3535 GENERAL ATOMICS COURT STE 200 SAN DIEGO CA 92121 KRISTIINA VUORI PRESIDENT/BOARD MEMBER 6.00 X X 25577 0 0 LOUIS COFFMAN THRU 523 CFO/BOARD MEMBER 1.00 X X 75579 0 0 KNOX BELL SECRETARY/BOARD MEMBER 1.00 X X 0 0 0 EDWARD HOLMES CHAIR 1.00 X 0 0 0 MICHAEL DOLLAR CFO 40.00 X 230983 0 16869 332139 0 16869 1 0 1 0 0 12000000 12000000 532763 532763 12532763 0 0 532763 349008 349008 886130 591371 294759 18446 11896 6550 143363 84729 58634 86730 43468 43262 13481 13481 22650 22650 280941 92037 188904 5515 5515 244258 46607 197651 1294995 1166172 128823 18886 10983 7903 19692 7360 12332 136332 135861 471 19892 6653 13239 SCIENTIFIC SUPPLIES 306224 306224 EQUIPMENT 75951 74150 1801 10723 1216 9507 3933217 2578727 1354490 0 12002975 299858 0 19113043 1082 30 0 320628 1550720 136331 0 1414389 0 4928695 12004057 26076643 18800 168669 10000000 10000000 0 5323171 10018800 15491840 X 1985257 10584803 1985257 10584803 12004057 26076643 8599546 0 X 0 1 X 1 0 X 2000000 12000000 14000000 2000000 12000000 14000000 14000000 1082 532763 533845 14533845 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 50911 4735 46176 1499809 131596 1368213 1414389 RIGHT OF USE ASSET 4913512 INTEREST RECEIVABLE 15183 4928695 DEFERRED LIABILITIES 409659 OPERATING LEASE LIABILITY 4913512 5323171 X 12533000 237 237 12532763 0 12532763 3933000 0 3933000 217 217 3933217 PART X, LINE 2: SANFORD LABS HAS NO UNRECOGNIZED TAX BENEFITS OR LIABILITIES AS OF DECEMBER 31, 2023 AND 2022. SANFORD LABS FILES AN EXEMPT ORGANIZATION RETURN IN THE UNITED STATES FEDERAL JURISDICTION AND WITH THE FRANCHISE TAX BOARD IN THE STATE OF CALIFORNIA. FOR THE YEAR ENDED DECEMBER 31, 2023 AND 2022, NO PROVISION FOR INCOME TAX HAS BEEN MADE. PART XI, LINE 2D - OTHER ADJUSTMENTS: ROUNDING PART XII, LINE 4B - OTHER ADJUSTMENTS: ROUNDING X X X 0 0 0 0 0 0 0 0 0 MICHAEL DOLLAR CFO 230983 0 0 0 0 0 5982 0 10887 0 247852 0 0 0 FORM 990, PART VI, SECTION B, LINE 11B THE FORM 990 HAS BEEN REVIEWED BY SENIOR MANAGEMENT, PRESIDENT, AND THE BOARD OF DIRECTORS. A FINAL VERSION OF THE FORM 990 HAS BEEN PROVIDED TO THE BOARD OF DIRECTORS PRIOR TO SUBMISSION. FORM 990, PART VI, SECTION B, LINE 12C SANFORD LABS REGULARLY AND CONSISTENTLY MONITORS AND ENFORCES THESE POLICIES IN ACCORDANCE WITH WRITTEN PROCEDURES. DUTY TO DISCLOSE. IN CONNECTION WITH ANY ACTUAL OR POSSIBLE CONFLICT OF INTEREST, AN INTERESTED PERSON MUST DISCLOSE THE EXISTENCE OF THE FINANCIAL INTEREST AND BE GIVEN THE OPPORTUNITY TO DISCLOSE ALL MATERIAL FACTS TO THE DIRECTORS AND/OR THE MEMBERS OF APPROPRIATE COMMITTEES WITH BOARD DELEGATED POWERS, IF ANY, CONSIDERING THE PROPOSED TRANSACTION OR ARRANGEMENT. ANY BOARD MEMBER WITH A CONFLICT IS NOT ALLOWED TO VOTE ON THE TRANSACTION. FORM 990, PART VI, SECTION B, LINE 15 SANFORD LABS ENGAGED A HUMAN RESOURCE CONSULTANT TO DETERMINE A SALARY RANGE FOR OFFICERS BASED ON COMPARABLE ORGANIZATIONS AND INDUSTRY. ALL INDEPENDENT BOARD MEMBERS REVIEW AND APPROVE THE RANGES, AND ANY SALARY INCREASES. EACH OFFICER HAS AN EMPLOYMENT AGREEMENT APPROVED BY THE INDEPENDENT BOARD DIRECTORS. THIS PROCESS LAST OCCURRED IN APRIL 2024. FORM 990, PART VI, SECTION C, LINE 19 THE ORGANIZATION MAKES ITS GOVERNING DOCUMENTS, CONFLICTS OF INTEREST POLICY, AND FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC UPON REQUEST.